Colorectal Cancer Trial, Recruiting NCT06043999 Sponsor: Sun Yat-sen University Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT06043999
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 75 years old
  • You have had a local surgical removal of a rectal cancer (adenocarcinoma) using one of several specific procedures (such as TEM, TAMIS, EMR, ESD, or polypectomy — confirm with trial site if unsure which applies to you)
  • Your tumor meets specific size and tissue characteristics: either it is between 3–5 cm with certain concerning features under the microscope (such as poor cell appearance, spread into blood/lymph vessels, or nerve involvement), or it is smaller than 3 cm with at least one of those features (confirm details with trial site)
  • At the time of first diagnosis, the tumor was located within 10 cm of the anal opening, as measured by MRI scan
  • At the time of first diagnosis, scans showed the cancer had not spread to lymph nodes or other parts of the body
  • You do not have more than one colorectal cancer at the same time
  • Your heart, lungs, liver, and kidneys are healthy enough to tolerate surgery
  • You and your family are willing to participate and have signed a written consent form

Who may not be able to join:

  • You have, or previously had, another type of cancer
  • You are not able to receive chemotherapy, radiation therapy, or surgery if needed later
  • You have a history of inflammatory bowel disease (IBD) or a condition called familial adenomatous polyposis (FAP)
  • You have recently been diagnosed with another cancer
  • Your overall physical health is rated as very poor based on standard medical scoring scales (confirm with trial site)
  • Your liver, kidneys, heart, or lungs are not healthy enough to tolerate surgery, or you have serious blood clotting problems or other major health conditions
  • You have a history of severe mental illness
  • You are pregnant or breastfeeding
  • You have other medical or test result conditions that the trial team decides make you ineligible (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 September 2023
Est. completion
31 December 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Three years disease-free survival rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov